Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

Bioinformatic analysis of HIV-1 entry and pathogenesis.

Aiamkitsumrit B, Dampier W, Antell G, Rivera N, Martin-Garcia J, Pirrone V, Nonnemacher MR, Wigdahl B.

Curr HIV Res. 2014;12(2):132-61. Review.

2.

How does HIV-1 infect a susceptible human cell?: Current thinking.

Al-Jabri AA.

J Sci Res Med Sci. 2003 Aug;5(1-2):31-44. Review.

3.

Affinofile profiling: how efficiency of CD4/CCR5 usage impacts the biological and pathogenic phenotype of HIV.

Chikere K, Chou T, Gorry PR, Lee B.

Virology. 2013 Jan 5;435(1):81-91. doi: 10.1016/j.virol.2012.09.043. Review.

4.

High CCR5 density on central memory CD4+ T cells in acute HIV-1 infection is mostly associated with rapid disease progression.

Yang X, Jiao YM, Wang R, Ji YX, Zhang HW, Zhang YH, Chen DX, Zhang T, Wu H.

PLoS One. 2012;7(11):e49526. doi: 10.1371/journal.pone.0049526. Epub 2012 Nov 21.

5.

Pillars article: HIV-1 entry cofactor: functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor. Science. 1996. 272: 872-877.

Feng Y, Broder CC, Kennedy PE, Berger EA.

J Immunol. 2011 Jun 1;186(11):6076-81. No abstract available.

6.

Biology and clinical relevance of chemokines and chemokine receptors CXCR4 and CCR5 in human diseases.

Choi WT, An J.

Exp Biol Med (Maywood). 2011 Jun 1;236(6):637-47. doi: 10.1258/ebm.2011.010389. Epub 2011 May 12. Review.

7.

Asymmetric HIV-1 co-receptor use and replication in CD4(+) T lymphocytes.

Mariani SA, Vicenzi E, Poli G.

J Transl Med. 2011 Jan 27;9 Suppl 1:S8. doi: 10.1186/1479-5876-9-S1-S8. Review.

8.

HSV type 2 infection increases HIV DNA detection in vaginal tissue of mice expressing human CD4 and CCR5.

Zariffard MR, Saifuddin M, Finnegan A, Spear GT.

AIDS Res Hum Retroviruses. 2009 Nov;25(11):1157-64. doi: 10.1089/aid.2009.0035.

9.

A formylpeptide receptor, FPRL1, acts as an efficient coreceptor for primary isolates of human immunodeficiency virus.

Shimizu N, Tanaka A, Mori T, Ohtsuki T, Hoque A, Jinno-Oue A, Apichartpiyakul C, Kusagawa S, Takebe Y, Hoshino H.

Retrovirology. 2008 Jun 25;5:52. doi: 10.1186/1742-4690-5-52.

10.

Neuroimmunity and the blood-brain barrier: molecular regulation of leukocyte transmigration and viral entry into the nervous system with a focus on neuroAIDS.

Buckner CM, Luers AJ, Calderon TM, Eugenin EA, Berman JW.

J Neuroimmune Pharmacol. 2006 Jun;1(2):160-81. Epub 2006 Apr 13. Review.

11.

CCR5, GPR15, and CXCR6 are major coreceptors of human immunodeficiency virus type 2 variants isolated from individuals with and without plasma viremia.

Blaak H, Boers PH, Gruters RA, Schuitemaker H, van der Ende ME, Osterhaus AD.

J Virol. 2005 Feb;79(3):1686-700.

12.

Elevated expression of GM3 in receptor-bearing targets confers resistance to human immunodeficiency virus type 1 fusion.

Rawat SS, Gallo SA, Eaton J, Martin TD, Ablan S, KewalRamani VN, Wang JM, Blumenthal R, Puri A.

J Virol. 2004 Jul;78(14):7360-8.

13.

Lv2, a novel postentry restriction, is mediated by both capsid and envelope.

Schmitz C, Marchant D, Neil SJ, Aubin K, Reuter S, Dittmar MT, McKnight A.

J Virol. 2004 Feb;78(4):2006-16.

14.

Potential role for CD63 in CCR5-mediated human immunodeficiency virus type 1 infection of macrophages.

von Lindern JJ, Rojo D, Grovit-Ferbas K, Yeramian C, Deng C, Herbein G, Ferguson MR, Pappas TC, Decker JM, Singh A, Collman RG, O'Brien WA.

J Virol. 2003 Mar;77(6):3624-33.

16.

Feline immunodeficiency virus cell entry.

Frey SC, Hoover EA, Mullins JI.

J Virol. 2001 Jun;75(11):5433-40.

17.

Susceptibility of the porcine endogenous retrovirus to reverse transcriptase and protease inhibitors.

Qari SH, Magre S, GarcĂ­a-Lerma JG, Hussain AI, Takeuchi Y, Patience C, Weiss RA, Heneine W.

J Virol. 2001 Jan;75(2):1048-53.

18.
19.
20.

A putative G protein-coupled receptor, RDC1, is a novel coreceptor for human and simian immunodeficiency viruses.

Shimizu N, Soda Y, Kanbe K, Liu HY, Mukai R, Kitamura T, Hoshino H.

J Virol. 2000 Jan;74(2):619-26.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk